inflammation

A Viral Risk Factor for Lupus

by Gertrud U. Rey Epstein-Barr virus (EBV) is a common human herpesvirus that typically spreads through saliva and is known for causing infectious mononucleosis (i.e., “mono”). There is an established causal link between infection with EBV and the development of multiple sclerosis. Emerging evidence now suggests that EBV may also play a significant role in …

A Viral Risk Factor for Lupus Read More »

Trial By Error: Interview with Columbia’s Ian Lipkin on Heightened Immune Response in ME/CFS, Funding Challenges, and Current Research

By David Tuller, DrPH Last week, a research team from Columbia University’s Center for Infection and Immunity published a paper called “Heightened innate immunity may trigger chronic inflammation, fatigue and post-exertional malaise in ME/CFS,” in the journal npj Metabolic Health and Disease. The senior investigator, Dr. W. Ian Lipkin, is director of the center and …

Trial By Error: Interview with Columbia’s Ian Lipkin on Heightened Immune Response in ME/CFS, Funding Challenges, and Current Research Read More »

A Universal Antiviral Drug

by Gertrud U. Rey There is currently no vaccine that is effective against all viruses and it is unlikely that one will ever exist. But what about a universal antiviral drug? A recent study out of Columbia University suggests that it might be possible to develop effective broad-spectrum antivirals against known, emerging, and unknown viruses. …

A Universal Antiviral Drug Read More »

Effect of Diabetes and Obesity on Influenza Outcomes

by Gertrud U. Rey Flu season is in full swing, and hospitalizations related to influenza virus infection are on the rise. During the 2009 “swine flu” pandemic it became evident that diabetes and obesity increase one’s risk for severe influenza disease, a correlation that was also later observed in the context of COVID-19. A series …

Effect of Diabetes and Obesity on Influenza Outcomes Read More »

TWiV 984: Clinical update with Dr. Daniel Griffin

In his weekly clinical update Dr. Griffin discusses the political polarization of COVID-19 treatments among physicians and laypeople in the United States, seven alternatives to evidence-based medicine, Malawi’s cholera death toll crosses 1,300 in its deadliest outbreak on record, impact of coronavirus infections on pediatric patients at a tertiary pediatric hospital, maternal mRNA COVID-19 vaccination during …

TWiV 984: Clinical update with Dr. Daniel Griffin Read More »

TWiV 953: Clinical update with Dr. Daniel Griffin

In his weekly clinical update Dr. Griffin discusses high demand for Amoxicillin causing shortages amid child RSV surge, epidemiologic and clinical features of children and adolescents aged <18 years with monkeypox, low risk of SARS-Cov-2 transmission by fomites, nucleocapsid antigenemia is a marker of acute SARS-CoV-2 infection, impact of community masking on COVID-19,  protection against Omicron from vaccination and …

TWiV 953: Clinical update with Dr. Daniel Griffin Read More »

Scroll to Top